M. Sasso

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Peter Eddowes, M. Sasso, Michael Allison et al. · Gastroenterology · 2019 · 1.3K citations · Full text

Hepatology, Liver Stiffness Measurement, Nonalcoholic Fatty Liver Disease +10

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Thomas Karlas, David Petroff, M. Sasso et al. · Journal of Hepatology · 2016 · 1.2K citations · Full text

Controlled Attenuation Parameter, Clinical Endpoint, Laboratory Medicine +3

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

M. Sasso, Michel Beaugrand, Victor de Lédinghen et al. · Ultrasound in Medicine & Biology · 2010 · 837 citations

Medical Ultrasound, Hepatology, Power Ultrasound +10

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

Philip N. Newsome, M. Sasso, Jonathan J Deeks et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 729 citations · Full text

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan^®: validation in chronic hepatitis C

M. Sasso, Iulia Tengher-Barna, Marianne Ziol et al. · Journal of Viral Hepatitis · 2011 · 214 citations